Lyra Therapeutics, Inc. (LYRA) Financials
Stock symbol LYRA is outdated, potentially delisted? Maybe it is available on other exchange?
LYRA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2025 | 43.7 million | 48.0 million |
| June 30, 2025 | 52.6 million | 51.0 million |
| March 31, 2025 | 56.3 million | 52.4 million |
| Dec. 31, 2024 | 66.3 million | 54.8 million |
LYRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2025 | -7.4 million | 34000 |
| June 30, 2025 | -6.6 million | 914000 |
| March 31, 2025 | -8.8 million | 825000 |
| Dec. 31, 2024 | -11.3 million | 1.9 million |
LYRA Net Income
No data available :(
LYRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2025 | 22.1 million | 26.7 million | 31.4 million |
| June 30, 2025 | 29.8 million | 27.9 million | 32.5 million |
| March 31, 2025 | 31.7 million | 29.1 million | 33.4 million |
| Dec. 31, 2024 | 40.6 million | 30.3 million | 34.4 million |
LYRA Shares Outstanding
LYRA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2025 | - | 4.0 million | 2.1 million | - |
| June 30, 2025 | 20000 | 5.1 million | 3.5 million | - |
| March 31, 2025 | - | 4.9 million | 3.3 million | - |
| Dec. 31, 2024 | 58000 | 6.4 million | 3.6 million | - |
LYRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2025 | 25000 | 100000 |
| June 30, 2025 | 183000 | 200000 |
| March 31, 2025 | 183000 | - |
| Dec. 31, 2024 | 209000 | - |
LYRA
Price: $0.73
52 week price:
Earnings Per Share: -22.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 10913
Market Capitalization: 878566